International Parkinson and Movement Disorder Society’s Post

A recent post-hoc analysis on prasinezumab investigated its potential effects on disease progression in various subpopulations of the PASADENA study. Dr. Gennaro Pagano dives into this exploratory analysis with the MDS Podcast. https://loom.ly/2Tvsp-M

  • No alternative text description for this image
Gennaro Pagano

Doctor. Neuroscientist. Drug Developer. Dream Builder.

1mo

Thank you for the opportunity to discuss these results Gennaro

To view or add a comment, sign in

Explore topics